ABCC7 p.Lys696Arg
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 21708286
[PubMed]
Fresquet F et al: "Orphan missense mutations in the cystic fibrosis transmembrane conductance regulator a three-step biological approach to establishing a correlation between genotype and phenotype."
No.
Sentence
Comment
61
The genotype was as follows: p.[Lys696Arg] (K696R).
X
ABCC7 p.Lys696Arg 21708286:61:32
status: NEWX
ABCC7 p.Lys696Arg 21708286:61:44
status: NEW97 Sequences of Site-Directed Mutagenesis Primers Mutation Sense oligonucleotide sequences L102P 5=-GTACAGCCTCTCTTACCGGGAAGAATCATAGCTTCC-3= L167R 5=-AAGAAGACTTTAAAGCGGTCAAGCCGTGTTCTAG-3= P574S 5=-GCTGATTTGTATTTATTAGACTCTTCTTTTGGATACCTAGATG-3= V562I 5=-AGAATTTCTTTAGCAAGAGCAATATACAAAGATGCTGATTTG-3= K696R 5=-CAGACTGGAGAGTTTGGGGAAAGAAGGAAGAATTCTATTCTC-3= P841R 5=-GATATGGAGAGCATACGAGCAGTGACTACATGG-3= CFTR Missense Mutation Biological Assay 3 JMD Month 2011, Vol. xx, No.
X
ABCC7 p.Lys696Arg 21708286:97:295
status: NEW109 Mixed Phenotype with P574S CFTR Variant The missense substitution p.[Pro574Ser] (P574S) lies within nucleotide-binding domain 1.
X
ABCC7 p.Lys696Arg 21708286:109:32
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:84
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:152
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:206
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:260
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:289
status: NEWX
ABCC7 p.Lys696Arg 21708286:109:331
status: NEW119 Decreased Activity of K696R and P841R CFTR Mutants Two missense mutations, K696R and p.[Pro841Arg] (P841R), are situated within the cytoplasmic regulator domain of CFTR.
X
ABCC7 p.Lys696Arg 21708286:119:22
status: NEWX
ABCC7 p.Lys696Arg 21708286:119:75
status: NEW123 [1210-12T(7)] ϩ [1210-12T(7)] CBAVD ϩ Ø Ø 5/F/37 p.[Lys696Arg] Asymptomatic (prenatal CF diagnostics) ϩ Ø Ø 6/M/33 c.
X
ABCC7 p.Lys696Arg 21708286:123:74
status: NEW133 After using Western blot analysis (Figure 3B), the proportions of core-glycosylated protein for K696R and P841R appear insignificantly different from that of WT-CFTR (n ϭ 3, data not shown).
X
ABCC7 p.Lys696Arg 21708286:133:96
status: NEW134 Moreover, we observe by iodide efflux experiments that both mutations have similar functional consequence on CFTR activity: the maximum activation is reduced to 49.67% Ϯ 2.61% (n ϭ 4) for K696R and to 45.10% Ϯ 4.94% (n ϭ 4) for P841R (Figure 3C).
X
ABCC7 p.Lys696Arg 21708286:134:200
status: NEW161 B A calreticulin egremS475P calreticulin egremS475P WT F508del P574S CFTR C WT F508del P574S CFTR C B CFTR NaKATPase B CFTR NaKATPase C WT P574S *** WT P574S ***** 00 WT P574S 0 00 00 00 00 **** 00 WT P574S 0 00 00 00 00 0 50 100 WT % of maximal activation 0 50 100 WT % of maximal activationB/(B+C) (%) 100 0 200 300 400 500 B/(B+C) (%) 100 0 200 300 400 500 Figure 2.
X
ABCC7 p.Lys696Arg 21708286:161:96
status: NEW162 P574S amino acid substitution decreases CFTR protein maturation.
X
ABCC7 p.Lys696Arg 21708286:162:200
status: NEW192 One possible explanation could be that iodide effluxes are not sensitive enough to precisely evaluate the CFTR chloride channel activation process; notably, CFTR channel open probability could not be studied directly by this A B C P841R actin merge +TO-PRO K696R actin merge +TO-PRO P841R actin merge +TO-PRO K696R actin merge +TO-PRO % of maximal activation ** ** 0 50 100 WT K696R P841R % of maximal activation ** ** 0 50 100 WT K696R P841R % of maximal activation ** ** 0 50 100 WT K696R P841R WT F508del P841R K696R B CFTR NaKATPase C WT F508del P841R K696R B CFTR NaKATPase C Figure 3.
X
ABCC7 p.Lys696Arg 21708286:192:257
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:309
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:377
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:431
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:485
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:514
status: NEWX
ABCC7 p.Lys696Arg 21708286:192:556
status: NEW193 K696R and P841R amino acid substitutions affect CFTR channel activity.
X
ABCC7 p.Lys696Arg 21708286:193:0
status: NEW207 Obviously, patch-clamp analysis would be useful to measure the real impact of P574S in CFTR channel gating.
X
ABCC7 p.Lys696Arg 21708286:207:12
status: NEW209 Our results suggest a mild phenotype for the K696R and P841R CFTR mutants: the trafficking and maturation rates appear normal, whereas activation is approximately half reduced.
X
ABCC7 p.Lys696Arg 21708286:209:45
status: NEW211 The variant K696R was isolated from a familial study, in which we did not find any other CFTR mutation.
X
ABCC7 p.Lys696Arg 21708286:211:12
status: NEW60 Sequences of Site-Directed Mutagenesis Primers Mutation Sense oligonucleotide sequences L102P 5=-GTACAGCCTCTCTTACCGGGAAGAATCATAGCTTCC-3= L167R 5=-AAGAAGACTTTAAAGCGGTCAAGCCGTGTTCTAG-3= P574S 5=-GCTGATTTGTATTTATTAGACTCTTCTTTTGGATACCTAGATG-3= V562I 5=-AGAATTTCTTTAGCAAGAGCAATATACAAAGATGCTGATTTG-3= K696R 5=-CAGACTGGAGAGTTTGGGGAAAGAAGGAAGAATTCTATTCTC-3= P841R 5=-GATATGGAGAGCATACGAGCAGTGACTACATGG-3= was presented.
X
ABCC7 p.Lys696Arg 21708286:60:295
status: NEW62 The genotype was as follows: p.Lys696Arg (K696R).
X
ABCC7 p.Lys696Arg 21708286:62:31
status: NEWX
ABCC7 p.Lys696Arg 21708286:62:42
status: NEW82 [1210-12T(7)] ϩ [1210-12T(7)] CBAVD ϩ Ø Ø 5/F/37 p.[Lys696Arg] Asymptomatic (prenatal CF diagnostics) ϩ Ø Ø 6/M/33 c.
X
ABCC7 p.Lys696Arg 21708286:82:74
status: NEW110 K696R and P841R amino acid substitutions affect CFTR channel activity.
X
ABCC7 p.Lys696Arg 21708286:110:0
status: NEW158 Decreased Activity of K696R and P841R CFTR Mutants Two missense mutations, p.Lys696Arg (K696R) and p.Pro841Arg (P841R), are situated within the cytoplasmic regulator domain of CFTR.
X
ABCC7 p.Lys696Arg 21708286:158:22
status: NEWX
ABCC7 p.Lys696Arg 21708286:158:77
status: NEWX
ABCC7 p.Lys696Arg 21708286:158:88
status: NEW205 Our results suggest a mild phenotype for the K696R and P841R CFTR mutants: the trafficking and maturation rates appear normal, whereas activation is approximately half reduced.
X
ABCC7 p.Lys696Arg 21708286:205:45
status: NEW